Artit Asiriwathanakul

Artit Asiriwathanakul serves as CEO of Bumrungrad International Hospital, one of the world's most recognized private healthcare institutions and a pioneer of medical tourism in Southeast Asia. The Bangkok-based hospital treats over 1 million patients annually, with approximately 40% coming from abroad — representing over 190 countries. Middle Eastern patients have historically been a particularly important segment. Bumrungrad operates 580+ beds with over 1,400 physicians covering virtually every medical specialty. The hospital achieved JCI (Joint Commission International) accreditation — the gold standard for international healthcare quality — and is consistently ranked among Asia's best hospitals. Its value proposition is compelling: world-class medical care at 40-60% lower costs than equivalent treatment in the United States, combined with Thailand's renowned hospitality culture. The hospital's revenue model benefits from premiumization — international patients and wealthy Thai patients opt for premium suites and specialized treatments that command higher margins. Key stock drivers include international patient volumes (particularly from the Middle East, Myanmar, Bangladesh, and Cambodia), Thai medical tourism policy, hospital bed utilization rates, physician recruitment, insurance partnerships, and competition from other premium Thai hospitals (Bangkok Dusit Medical, Samitivej) and regional competitors in Singapore, Malaysia, and India.